Source: BIOSPACE

Ossianix: <b>Ossianix</b> Expands And Extends Its Research Collaboration With H. Lundbeck A/S On CNS Therapeutics

PHILADELPHIA--(www.businesswire.com/">BUSINESS WIRE)--Ossianix, Inc. today announced an expansion and extension of its strategic research collaboration with H. Lundbeck A/S (Lundbeck). This collaboration follows a previous equity investment in 2012 and prior research collaboration in 2013. The collaboration will use Ossianixs ...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more